Literature DB >> 21922154

Provision of contraceptive services to women with diabetes mellitus.

Eleanor Bimla Schwarz1, Debbie Postlethwaite, Yun-Yi Hung, Eric Lantzman, Mary Anne Armstrong, Michael A Horberg.   

Abstract

BACKGROUND: Women with diabetes mellitus who delay pregnancy until glycemic control is achieved experience lower rates of adverse pregnancy outcomes.
OBJECTIVE: To compare rates of provision of contraceptive services among women with diabetes mellitus and women without chronic medical conditions.
DESIGN: A retrospective cohort study of 459,181 women aged 15-44 who had continuous membership and pharmacy benefits in a managed care organization in Northern California between January 2006 and June 2007. Rates of documented provision of contraceptive counseling, prescriptions, and services were compared between women with diabetes and women without chronic medical conditions.
RESULTS: Among 8,182 women with diabetes and 122,921 women without any chronic conditions, women with diabetes were less likely than women without a chronic condition to have documented receipt of any contraceptive counseling, prescriptions, or services (47.8% vs 62.0%, p < 0.001). After controlling for age and race, women with diabetes were more likely to have undergone tubal sterilization compared to women without a chronic condition (OR = 1.41, 95% CI 1.30-1.54), but less likely to have received highly effective, reversible methods of contraception such as intrauterine contraception (OR = 0.68, 95% CI 0.61-0.75). In addition, more women with diabetes had undergone hysterectomy, which is rarely performed solely for contraceptive purposes.
CONCLUSIONS: Women with diabetes were less likely to receive highly effective reversible contraception and more likely to undergo sterilization procedures. Increasing the use of highly effective reversible contraceptives may help diabetic women who want to retain their fertility to delay pregnancy until glycemic control is achieved.

Entities:  

Mesh:

Year:  2011        PMID: 21922154      PMCID: PMC3270235          DOI: 10.1007/s11606-011-1875-6

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  28 in total

Review 1.  Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States.

Authors:  Kathryn M Curtis; Denise J Jamieson; Herbert B Peterson; Polly A Marchbanks
Journal:  Contraception       Date:  2010-03-29       Impact factor: 3.375

2.  Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization.

Authors:  Liyan Liu; James E Allison; Lisa J Herrinton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-11       Impact factor: 2.890

3.  Providers' perspectives on challenges to contraceptive counseling in primary care settings.

Authors:  Aletha Y Akers; Melanie A Gold; Sonya Borrero; Aimee Santucci; Eleanor B Schwarz
Journal:  J Womens Health (Larchmt)       Date:  2010-06       Impact factor: 2.681

4.  Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning.

Authors:  Katarzyna Cyganek; Alicja Hebda-Szydlo; Barbara Katra; Jan Skupien; Tomasz Klupa; Izabela Janas; Irena Kaim; Jacek Sieradzki; Alfred Reron; Maciej T Malecki
Journal:  Diabetes Technol Ther       Date:  2010-01       Impact factor: 6.118

Review 5.  Preconception care of women with diabetes: a review of current guideline recommendations.

Authors:  Maimunah Mahmud; Danielle Mazza
Journal:  BMC Womens Health       Date:  2010-01-31       Impact factor: 2.809

6.  Preconception and interconception health status of women who recently gave birth to a live-born infant--Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004.

Authors:  Denise D'Angelo; Letitia Williams; Brian Morrow; Shanna Cox; Norma Harris; Leslie Harrison; Samuel F Posner; Jessie Richardson Hood; Lauren Zapata
Journal:  MMWR Surveill Summ       Date:  2007-12-14

7.  Trends and correlates of HIV testing during pregnancy in racially/ethnically diverse insured population, 1997-2006.

Authors:  Jean M Lawrence; In-Lu A Liu; William J Towner
Journal:  Matern Child Health J       Date:  2008-08-19

8.  Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-01-11       Impact factor: 17.586

9.  Hormonal contraception and risk of venous thromboembolism: national follow-up study.

Authors:  Øjvind Lidegaard; Ellen Løkkegaard; Anne Louise Svendsen; Carsten Agger
Journal:  BMJ       Date:  2009-08-13

10.  Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006.

Authors:  Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 17.152

View more
  14 in total

1.  Contraceptive Use Among Women with Prediabetes and Diabetes in a US National Sample.

Authors:  Laura E Britton; Jon M Hussey; Diane C Berry; Jamie L Crandell; Jada L Brooks; Amy G Bryant
Journal:  J Midwifery Womens Health       Date:  2018-12-12       Impact factor: 2.388

2.  Pattern of contraceptive use among reproductive-aged women with diabetes and/or hypertension: findings from Bangladesh Demographic and Health Survey.

Authors:  Md Nuruzzaman Khan; M Mofizul Islam; Rakibul M Islam
Journal:  BMC Womens Health       Date:  2022-06-15       Impact factor: 2.742

3.  A model for building a national, patient-driven database to track contraceptive use in women with rare diseases.

Authors:  Tatiana Josephy; Deena R Loeffler; Molly Pam; Emily M Godfrey
Journal:  J Am Med Inform Assoc       Date:  2022-01-12       Impact factor: 7.942

4.  Medical contraindications to estrogen and contraceptive use among women veterans.

Authors:  Colleen P Judge; Xinhua Zhao; Florentina E Sileanu; Maria K Mor; Sonya Borrero
Journal:  Am J Obstet Gynecol       Date:  2017-10-27       Impact factor: 8.661

5.  Contraceptive Counseling and Use among Women with Poorer Health.

Authors:  Jessica K Lee; Sara M Parisi; Eleanor Bimla Schwarz
Journal:  J Womens Health Issues Care       Date:  2013

6.  Contraceptive methods and informed consent among women receiving medications with potential for adverse fetal effects: a Washington, Wyoming, Alaska, Montana, Idaho (WWAMI) region study.

Authors:  Rex W Force; Gina A Keppel; Janelle Guirguis-Blake; Debra A Gould; Chris Vincent; Kavitha Chunchu; Robert M Monger; John T Holmes; Jacintha Cauffield; Laura-Mae Baldwin
Journal:  J Am Board Fam Med       Date:  2012 Sep-Oct       Impact factor: 2.657

Review 7.  Contraception for women with diabetes: challenges and solutions.

Authors:  Ann Robinson; Chidiebere Nwolise; Jill Shawe
Journal:  Open Access J Contracept       Date:  2016-03-03

8.  A Web-Based Decision Tool to Improve Contraceptive Counseling for Women With Chronic Medical Conditions: Protocol For a Mixed Methods Implementation Study.

Authors:  Justine P Wu; Laura J Damschroder; Michael D Fetters; Brian J Zikmund-Fisher; Benjamin F Crabtree; Shawna V Hudson; Mack T Ruffin; Juliana Fucinari; Minji Kang; L Susan Taichman; John W Creswell
Journal:  JMIR Res Protoc       Date:  2018-04-18

Review 9.  The challenges and future considerations regarding pregnancy-related outcomes in women with pre-existing diabetes.

Authors:  Harsimran Singh; Helen R Murphy; Christel Hendrieckx; Lee Ritterband; Jane Speight
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

10.  A theoretical model of contraceptive decision-making and behaviour in diabetes: A qualitative application of the Health Belief Model.

Authors:  Emily Johnson; Melissa DeJonckheere; Andrea L Oliverio; Kathryn S Brown; Murphy Van Sparrentak; Justine P Wu
Journal:  Diabet Med       Date:  2020-11-06       Impact factor: 4.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.